Cytotoxic CD8+ T cells in cancer and cancer immunotherapy H Raskov, A Orhan, JP Christensen, I Gögenur British journal of cancer 124 (2), 359-367, 2021 | 1301 | 2021 |
The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis A Orhan, RP Vogelsang, MB Andersen, MT Madsen, ER Hölmich, ... European journal of cancer 132, 71-84, 2020 | 144 | 2020 |
Cancer-associated fibroblasts and tumor-associated macrophages in cancer and cancer immunotherapy H Raskov, A Orhan, S Gaggar, I Gögenur Frontiers in oncology 11, 668731, 2021 | 98 | 2021 |
Neutrophils and polymorphonuclear myeloid-derived suppressor cells: an emerging battleground in cancer therapy H Raskov, A Orhan, S Gaggar, I Gögenur Oncogenesis 11 (1), 22, 2022 | 45 | 2022 |
Electroporation and immunotherapy—unleashing the abscopal effect TF Justesen, A Orhan, H Raskov, C Nolsoe, I Gögenur Cancers 14 (12), 2876, 2022 | 43 | 2022 |
Natural killer cells in cancer and cancer immunotherapy H Raskov, A Orhan, A Salanti, S Gaggar, I Gögenur cancer letters 520, 233-242, 2021 | 30 | 2021 |
Premetastatic niches, exosomes and circulating tumor cells: Early mechanisms of tumor dissemination and the relation to surgery H Raskov, A Orhan, A Salanti, I Gögenur International journal of cancer 146 (12), 3244-3255, 2020 | 29 | 2020 |
Tumor-infiltrating lymphocytes as biomarkers of treatment response and long-term survival in patients with rectal cancer: a systematic review and meta-analysis A Orhan, F Khesrawi, M Tvilling Madsen, R Peuliche Vogelsang, N Dohrn, ... Cancers 14 (3), 636, 2022 | 22 | 2022 |
Prediction of 90-day mortality after surgery for colorectal cancer using standardized nationwide quality-assurance data RP Vogelsang, RD Bojesen, ER Hoelmich, A Orhan, F Buzquurz, L Cai, ... BJS open 5 (3), zrab023, 2021 | 20 | 2021 |
The Matrix Reloaded - The Role of the Extracellular Matrix in Cancer H Raskov, S Gaggar, A Tajik, A Orhan, I Gögenur Cancers (Basel) 15 (7), 2057, 2023 | 16 | 2023 |
The intestinotrophic effects of glucagon-like peptide-2 in relation to intestinal neoplasia A Orhan, I Gögenur, H Kissow The Journal of Clinical Endocrinology & Metabolism 103 (8), 2827-2837, 2018 | 16 | 2018 |
T cells in cancer and cancer immunotherapy., 2021, 124 H Raskov, A Orhan, JP Christensen, IGC CD DOI: https://doi. org/10.1038/s41416-020-01048-4. PMID: https://www. ncbi …, 0 | 16 | |
Metabolic switch in cancer–survival of the fittest H Raskov, S Gaggar, A Tajik, A Orhan, I Gögenur European Journal of Cancer 180, 30-51, 2023 | 14 | 2023 |
Long-Term outcomes after use of perioperative glucocorticoids in patients undergoing cancer surgery: a systematic review and meta-analysis E Rosenkrantz Hölmich, R Petring Hasselager, M Tvilling Madsen, ... Cancers 12 (1), 76, 2019 | 13 | 2019 |
Myocardial injury after colorectal cancer surgery and postoperative 90-day mortality and morbidity: a retrospective cohort study JA Zahid, A Orhan, S Ekeloef, I Gögenur Diseases of the Colon & Rectum 64 (12), 1531-1541, 2021 | 6 | 2021 |
Introducing neoadjuvant immunotherapy for colorectal cancer: advancing the frontier A Orhan, TF Justesen, H Raskov, C Qvortrup, I Gögenur Annals of Surgery 281 (1), 95-104, 2025 | 3 | 2025 |
The prognostic value of tumour-infiltrating lymphocytes (TILs) in pancreatic cancer: a systematic review and meta-analysis A Orhan, RP Vogelsang, MB Andersen, MT Madsen, ER Hölmich, ... Annals of Oncology 30, xi2-xi3, 2019 | 3 | 2019 |
The impact of platelets on the metastatic potential of tumour cells H Raskov, A Orhan, MØ Agerbæk, I Gögenur Heliyon, 2024 | 2 | 2024 |
Digitally assessed lymphocyte infiltration in rectal cancer biopsies is associated with pathological response to neoadjuvant therapy DNM Jepsen, H Høeg, M Bzorek, A Orhan, JO Eriksen, I Gögenur, B Reiss, ... Human Pathology 144, 61-70, 2024 | 2 | 2024 |
Mismatch Repair Status and Surgical Outcomes in Localized Colorectal Cancer: A Nationwide Cohort Study TF Justesen, A Orhan, AW Rosen, M Gögenur, I Gögenur Annals of Surgery Open 5 (4), e499, 2024 | 1 | 2024 |